Login / Signup

Chemotherapy resumption in breast cancer patient after COVID-19.

Julian HoriguchiAyako NakashojiNaoki KawaharaAkira MatsuiTakayuki Kinoshita
Published in: Surgical case reports (2021)
Evaluating the risk for each patient is essential when resuming anti-cancer therapy in cancer patient's post-COVID-19.
Keyphrases
  • coronavirus disease
  • case report
  • sars cov
  • cancer therapy
  • drug delivery
  • squamous cell carcinoma
  • radiation therapy
  • papillary thyroid
  • locally advanced